The burden of cancer, mental illness and other diseases is growing and according to a report by Statista, residents aged 65 years and above make up 16.6 percent of the total resident population in Singapore. This makes early health intervention critical in addressing these national healthcare issues,
So how is Johnson & Johnson Innovation – JLABS recent collaboration with EDB enabling and empowering emerging healthcare companies with the knowledge, experience and venture connections across a spectrum of pharmaceutical and medical technology sectors?
Melinda Richter, Global Head, Johnson & Johnson Innovation – JLABS shares more.

What’s Trending: Hour-long alarms haunting Tiong Bahru, a retirement home for Gen Zs & what’s inside our safe deposit box?
21:52

Wealth Tracker: Is AI everything in 2026 investment portfolios?
16:18

Market View: Oil prices, gold retreat as Trump calms Iran fears; Trump imposes 25% tariff on imports of some AI chips; Alibaba to link Taobao shopping to main AI app; Bank of Korea stands pat; UOB, Sembcorp, Advanced Systems Automation to watch
14:15